NO20042143L - Fremgangsmate for fremstilling av raskt opplosende preparater med hoyt innhold av ribavirin - Google Patents
Fremgangsmate for fremstilling av raskt opplosende preparater med hoyt innhold av ribavirinInfo
- Publication number
- NO20042143L NO20042143L NO20042143A NO20042143A NO20042143L NO 20042143 L NO20042143 L NO 20042143L NO 20042143 A NO20042143 A NO 20042143A NO 20042143 A NO20042143 A NO 20042143A NO 20042143 L NO20042143 L NO 20042143L
- Authority
- NO
- Norway
- Prior art keywords
- ribavirin
- preparation
- dissolving preparations
- high content
- content
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 2
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960000329 ribavirin Drugs 0.000 title 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33685301P | 2001-11-02 | 2001-11-02 | |
| PCT/US2002/034899 WO2003039517A1 (en) | 2001-11-02 | 2002-10-31 | Process for preparing quick dissolving, high loading ribavirin compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042143L true NO20042143L (no) | 2004-05-25 |
Family
ID=23317956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042143A NO20042143L (no) | 2001-11-02 | 2004-05-25 | Fremgangsmate for fremstilling av raskt opplosende preparater med hoyt innhold av ribavirin |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030104050A1 (pl) |
| EP (1) | EP1443911A1 (pl) |
| JP (1) | JP2005511587A (pl) |
| KR (1) | KR20050042035A (pl) |
| CN (1) | CN1585631A (pl) |
| AU (1) | AU2002350082B9 (pl) |
| BR (1) | BR0213861A (pl) |
| CA (1) | CA2465159A1 (pl) |
| HR (1) | HRP20040384A2 (pl) |
| HU (1) | HUP0402364A2 (pl) |
| IL (1) | IL161697A0 (pl) |
| MX (1) | MXPA04004181A (pl) |
| NO (1) | NO20042143L (pl) |
| PL (1) | PL368550A1 (pl) |
| RU (1) | RU2004116821A (pl) |
| WO (1) | WO2003039517A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6720000B2 (en) | 2001-03-19 | 2004-04-13 | Three Rivers Pharmaceutical, Llc | Process for producing wet ribavirin pellets |
| US7538094B2 (en) * | 2002-09-19 | 2009-05-26 | Three Rivers Pharmacueticals, Llc | Composition containing ribavirin and use thereof |
| CZ298224B6 (cs) * | 2003-04-29 | 2007-07-25 | Pliva Istrazivanje I Razvoj D.O.O. | Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby |
| GEP20094681B (en) * | 2004-05-24 | 2009-05-10 | Nycomed Pharma As | Agglomeration of calcium-containing compound obtained by roller compaction |
| US20080124400A1 (en) * | 2004-06-24 | 2008-05-29 | Angiotech International Ag | Microparticles With High Loadings Of A Bioactive Agent |
| US7723310B2 (en) * | 2004-10-18 | 2010-05-25 | Three Rivers Pharmaceuticals, Llc | Large dose ribavirin formulations |
| US20060110479A1 (en) * | 2004-11-24 | 2006-05-25 | Mitra Shankar K | Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof |
| US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
| US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
| US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
| MX2009006699A (es) * | 2006-12-21 | 2009-06-30 | Mallinckrodt Inc | Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos. |
| US8202996B2 (en) * | 2007-12-21 | 2012-06-19 | Bristol-Myers Squibb Company | Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide |
| WO2010062996A2 (en) * | 2008-11-28 | 2010-06-03 | Adamas Pharmaceuticals, Inc. | Ribavirin composition |
| EP2295037A1 (en) | 2009-09-11 | 2011-03-16 | Ratiopharm GmbH | Pharmaceutical formulation containing Ribavirin |
| EP2583681A4 (en) * | 2010-06-08 | 2014-01-01 | Diagnostico Gam S A Lab De | ORAL VETERINARY COMPOSITION FOR SALMONIDS COMPRISING 1-BETA-D-RIBOFURANOSYL-1H-1,2,4-TRIAZOL-3-CARBOXAMIDE AND USE FOR THE TREATMENT OF INFECTIOUS SALMON ANEMIA (ISA) IN SALMONIDS |
| EP3307327A1 (en) * | 2015-06-09 | 2018-04-18 | Commonwealth Scientific and Industrial Research Organisation | Antiviral conjugates of polyanionic polymer and antiviral drug |
| CN106806345B (zh) * | 2015-11-27 | 2020-10-13 | 北京科信必成医药科技发展有限公司 | 一种利巴韦林掩味颗粒及其制备方法 |
| CN108464972A (zh) * | 2018-07-02 | 2018-08-31 | 福州大学 | 一种含有斯诺普利的抗肺动脉高压口服片剂及其制备方法 |
| AU2021292406B2 (en) | 2020-06-18 | 2024-03-14 | XWPharma Ltd. | Controlled release granulations of water-soluble active pharmaceutical ingredients |
| AU2021357705B2 (en) | 2020-10-05 | 2024-09-26 | XWPharma Ltd. | Modified release compositions of a gamma-hydroxybutyric acid derivative |
| CN113304114B (zh) * | 2021-06-08 | 2022-06-10 | 药大制药有限公司 | 一种利巴韦林颗粒及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3277520A (en) * | 1963-06-18 | 1966-10-11 | Fuji Denki Kogyo Kabushiki Kai | Method and apparatus for making spherical granules |
| US3927216A (en) * | 1971-06-01 | 1975-12-16 | Icn Pharmaceuticals | 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections |
| US3798209A (en) * | 1971-06-01 | 1974-03-19 | Icn Pharmaceuticals | 1,2,4-triazole nucleosides |
| US4211771A (en) * | 1971-06-01 | 1980-07-08 | Robins Ronald K | Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide |
| US3976545A (en) * | 1973-03-12 | 1976-08-24 | Icn Pharmaceuticals, Inc. | 1,2,4-Triazol E-3-carboxamides as antiviral agents |
| US3948885A (en) * | 1973-03-19 | 1976-04-06 | Icn Pharmaceuticals, Inc. | 5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside |
| US4138547A (en) * | 1977-12-22 | 1979-02-06 | Icn Pharmaceuticals, Inc. | Process for preparing 1,2,4-triazole nucleosides |
| US4439453A (en) * | 1980-12-22 | 1984-03-27 | Monsanto Company | Directly compressible acetaminophen granulation |
| GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| US5405837A (en) * | 1993-05-18 | 1995-04-11 | Indiana University Foundation | Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| ES2214551T3 (es) * | 1995-11-02 | 2004-09-16 | Schering Corporation | Terapia de infusion continua de citocinas a baja dosis. |
| US5908621A (en) * | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
| US6150337A (en) * | 1996-01-23 | 2000-11-21 | Icn Pharmaceuticals, Inc. | Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes |
| US5767097A (en) * | 1996-01-23 | 1998-06-16 | Icn Pharmaceuticals, Inc. | Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
| SK284054B6 (sk) * | 1996-10-16 | 2004-08-03 | Icn Pharmaceuticals, Inc. | Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie |
| US6172046B1 (en) * | 1997-09-21 | 2001-01-09 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection |
| US6472373B1 (en) * | 1997-09-21 | 2002-10-29 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
| US5914128A (en) * | 1997-12-22 | 1999-06-22 | Schering Corporation | Orally administrable solid dosage form |
| DK0991415T3 (da) * | 1997-12-22 | 2003-06-16 | Schering Corp | Faste, oralt indgivelige dosisformer for ribavirin og fremgangsmåde til fremstilling af disse |
| US5916594A (en) * | 1997-12-22 | 1999-06-29 | Schering Corporation | Process of making solid ribavirin dosage forms |
| US20030104048A1 (en) * | 1999-02-26 | 2003-06-05 | Lipocine, Inc. | Pharmaceutical dosage forms for highly hydrophilic materials |
| US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US6720000B2 (en) * | 2001-03-19 | 2004-04-13 | Three Rivers Pharmaceutical, Llc | Process for producing wet ribavirin pellets |
-
2002
- 2002-10-31 PL PL02368550A patent/PL368550A1/pl not_active Application Discontinuation
- 2002-10-31 AU AU2002350082A patent/AU2002350082B9/en not_active Ceased
- 2002-10-31 EP EP02786613A patent/EP1443911A1/en not_active Withdrawn
- 2002-10-31 WO PCT/US2002/034899 patent/WO2003039517A1/en not_active Ceased
- 2002-10-31 KR KR1020047006543A patent/KR20050042035A/ko not_active Withdrawn
- 2002-10-31 MX MXPA04004181A patent/MXPA04004181A/es unknown
- 2002-10-31 CN CNA028222172A patent/CN1585631A/zh active Pending
- 2002-10-31 HR HR20040384A patent/HRP20040384A2/hr not_active Application Discontinuation
- 2002-10-31 BR BR0213861-1A patent/BR0213861A/pt not_active IP Right Cessation
- 2002-10-31 US US10/285,188 patent/US20030104050A1/en not_active Abandoned
- 2002-10-31 RU RU2004116821/15A patent/RU2004116821A/ru not_active Application Discontinuation
- 2002-10-31 CA CA002465159A patent/CA2465159A1/en not_active Abandoned
- 2002-10-31 JP JP2003541808A patent/JP2005511587A/ja active Pending
- 2002-10-31 HU HU0402364A patent/HUP0402364A2/hu unknown
- 2002-10-31 IL IL16169702A patent/IL161697A0/xx unknown
-
2004
- 2004-05-25 NO NO20042143A patent/NO20042143L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL368550A1 (pl) | 2005-04-04 |
| KR20050042035A (ko) | 2005-05-04 |
| EP1443911A1 (en) | 2004-08-11 |
| CN1585631A (zh) | 2005-02-23 |
| AU2002350082B2 (en) | 2006-07-20 |
| CA2465159A1 (en) | 2003-05-15 |
| MXPA04004181A (es) | 2005-01-25 |
| JP2005511587A (ja) | 2005-04-28 |
| WO2003039517A1 (en) | 2003-05-15 |
| HUP0402364A2 (hu) | 2005-02-28 |
| HRP20040384A2 (en) | 2005-08-31 |
| AU2002350082B9 (en) | 2006-08-31 |
| BR0213861A (pt) | 2004-12-21 |
| IL161697A0 (en) | 2004-09-27 |
| US20030104050A1 (en) | 2003-06-05 |
| RU2004116821A (ru) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
| AU2003233010A8 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
| NO20001648L (no) | FremgangsmÕter og mellomprodukter for fremstilling av anti- cancerforbindelser | |
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| CY2007029I1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| IL146389A0 (en) | Process for the preparation of dronedarone | |
| NO20013942D0 (no) | Fremgangsmate for fremstilling av Citalopram | |
| IS6531A (is) | Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það | |
| EP1432721A4 (en) | PROCESS FOR THE PREPARATION OF REBECCAMYCIN AND ANALOGUE THEREOF | |
| EE04490B1 (et) | Ühend, selle valmistamise meetod ning kasutamine meditsiinis | |
| NO20030163L (no) | Fremgangsmate for fremstilling av olefiner | |
| NO20040278L (no) | Fremgangsmate for fremstilling av perindopril | |
| NO20032731D0 (no) | Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner | |
| HUP0401600A3 (en) | Process for the preparation of 14-hydroxymorphine derivatives | |
| EP1261623A4 (en) | RETINOL DERIVATIVES, METHOD OF ITS PRESENTATIONS AND THEIR USES | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| AU2003271037A1 (en) | The extractive of aweto and process for its preparation and uses | |
| NO20042640L (no) | Fremgangsmate for fremstilling av ekinocandinderivater | |
| NO20013735D0 (no) | Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner | |
| NO20023445L (no) | Fremgangsmåte for fremstilling av peptider | |
| NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon | |
| NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| NO20035586D0 (no) | Fremgangsmåte for fremstilling av cykloheksanol-derivater | |
| AU2003276844A8 (en) | Formulations of modified antibodies and methods of making the same | |
| DK1341758T3 (da) | Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |